n=180 4-period full replicate [Design Issues]

posted by Achievwin – US, 2024-05-17 15:45 (32 d 02:43 ago) – Posting: # 24000
Views: 1,096

❝ there is clear requirement to improve T/R ratio from 0.85 to at least 0.9 -

that is commonsense if you ask a BE guy..... then formulators show 100s for documents that the formulations compare "Spot on" then starts navigation through muddy waters.

Complete thread:

UA Flag
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
100 visitors (0 registered, 100 guests [including 6 identified bots]).
Forum time: 18:28 CEST (Europe/Vienna)

You should treat as many patients as possible with the new drugs
while they still have the power to heal.    Armand Trousseau

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz